Background
==========

Non-Hodgkin's lymphoma (NHL) subgroups, immunophenotypes, and genotypes have been defined in developed countries but how that information translates to resource-constrained sub-Saharan Africa medical settings is undocumented. Local published data on NHL subgroups come largely from retrospective clinical biopsy study sets of paraffin-embedded tissues filed in local pathology archives. Relatively poorer representation of the rural and low socioeconomic populations is likely in such data. Prospectively identified NHL subgroups using immunologic and molecular techniques in consecutive presentations of patients would best clarify NHL subgroups and confounding diagnoses.

Materials and methods
=====================

Approximately 456 cases of malignant lymphoma (ML) from both the sub-Saharan African Lymphoma Consortium and Mid-region AIDS and Cancer Specimen Resource (ACSR) projects in East Africa were examined for microscopic morphology and 30 monoclonal antibodies for common NHL antigens; Lana-1 for HHV-8 (immunohistochemical, IHC); in situ hybridization (ISH) for EBV-encoded RNA, kappa/lambda light chains (Ventana, Tucson, AZ); and fluorescent in situ hybridization (FISH) c-myc t(8;14) (Abbott/Vysis, Downer's Grove, IL).

Results
=======

There was a small but consistent population of other tumors that reduced the accuracy of both the clinical and histopathology diagnosis of NHLs including those given in Table [1](#T1){ref-type="table"}.

###### 

Confounding tumor look-alikes.

  Tumor                               Subtype examples/confounding factors                   Presentation or clinical classification
  ----------------------------------- ------------------------------------------------------ -----------------------------------------
  Fungal infections                   African histoplasmosis                                 Kaposi's sarcoma
                                      Entomophthoromycosis -- *Basidiobolus ranarum*         NHL
                                                                                             
                                      HIV-1 lymphadenopathy, follicular hyperplasia          NHL
  Viral lymphadenopathy               EBV lymphadenopathy or lymphoproliferative disorders   NHL
                                      HHV-8 lymphoblastic lymphoma                           Burkitt lymphoma
                                      Castleman's disease                                    Atypical hyperplasia
                                                                                             
  Pediatric small round cell tumors   Undifferentiated neuroblastoma                         Burkitt lymphoma
                                      Primitive neuroectodermal tumors (PNET)                Burkitt lymphoma
                                                                                             
  Hodgkin's disease                   Lymphocyte predominant                                 Burkitt lymphoma
                                                                                             
  Carcinomas                          Poorly differentiated                                  NHL

Conclusions
===========

Clinical diagnosis of NHL is complicated by other pathological entities that lead to inaccuracies. Histopathology diagnosis based on hematoxylin and eosin (H&E) stained tissue morphology alone improves accuracy (vs. clinical diagnoses alone) but can provide additional inaccuracies due to tumor look-alikes. Caution is warranted in considering either clinical diagnosis or local histopathology diagnosis in a resource-constrained medical setting as accurate in the conduct of clinical treatment trials or epidemiology studies.
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